Unlicensed medicines
18 results
Applied filters
Understanding unlicensed medicines
28 July 2023An understanding of the different types of unlicensed medicine will help in meeting patients' special clinical needs
Labelling and packaging of unlicensed medicines (Specials): best practice guidance for the NHS
1 March 2022National guidance from NHSE/I to reduce LASA errors and improve patient safety when considering requirements for unlicensed specials medicines
Unlicensed medicines and use of PGDs
16 November 2021This page explains why PGDs are not a legal mechanism for the administration or supply of unlicensed medicines.
Unlicensed medicines
All our advice relating to making, purchasing and using unlicensed medicines.
Off-label or unlicensed product use under HMR 2012 exemptions
8 January 2020A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012
Using Standardised Strengths of Unlicensed Liquid Medicines in Children
10 October 2019A joint statement from the Neonatal and Paediatric Pharmacy Group (NPPG) and the Royal College of Paediatrics and Child Health (RCPCH)
Risk Associated with the Outsourcing of the Aseptic Compounding of Parenteral Nutrition (Yellow Cover)
16 December 2016The purpose of this document is to give guidance to those outsourcing PN compounding on the risks in the outsourcing and supply process and to…
Guidance on Managing The Sourcing and Supply of Ready-to-Administer Chemotheraphy Doses for the NHS (Yellow Cover)
5 December 2016This document is aimed at staff in UK NHS hospitals considering or already sourcing their supply of chemotherapy as ready-to-administer doses.